#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alpha-1 antitrypsin deficiency Paroxysmal nocturnal haemoglobinuria Adenomatous polyposis coli Bronchopulmonary dysplasia Nasopharyngeal cancer Metachromatic leukodystrophy Acute on chronic liver failure Infertility female Arrhythmogenic right ventricular dysplasia Crohn's disease Colon cancer Retinitis pigmentosa Burkitt's lymphoma refractory Chronic myeloid leukaemia (in remission) Prophylaxis against transplant rejection More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Basic Information Ewing’s sarcoma metastatic – Diagnostics Leiomyosarcoma recurrent – Trials in Disease Factor IX deficiency – Diagnostics Leiomyosarcoma metastatic – Basic Information Mucous membrane pemphigoid – Diagnostics Nephroblastoma – Treatment Leukoencephalopathy – Life with Disease Immunodeficiency congenital Marfan’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Migalastat Zinc Acetate Dihydrate Infigratinib Glipizide Hypothalamic Phospholipids Dexamethasone Acetate Rbd4059 Amivantamab Camlipixant Epcoritamab Taminadenant Potassium Oxybate Polydextrose OMECAMTIV MECARBIL Clomipramine Hydrochloride Lenalidomide Human Immunoglobulin G Micafungin O15-Water 7-Ethyl-10-Hydroxycamptothecin More therapies…

    Learn about Your Condition

    Oesophagectomy Wiskott-Aldrich syndrome Hyperthyroidism Lymphoedema VEXAS syndrome Pre-eclampsia Parkinson's disease Drug use disorder Corneal dystrophy Cutaneous sarcoidosis Mitochondrial DNA depletion Drug eruption Postprandial hypoglycaemia Pseudomyxoma peritonei Primary myelofibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Palbociclib
    • Inavolisib
    • Letrozole
    France Germany Italy Poland Spain

  • Study on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Cemiplimab
    • Allogeneic Faecal Microbiota, Pooled
    • Bevacizumab
    France

  • Study of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Calcium Folinate
    • Buclizine Hydrochloride
    Czechia France Germany Italy Norway

  • Study on Mannitol and Normal Saline for Patients with End-Stage Renal Disease Undergoing Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • End stage renal disease
    • Renal transplant
    Investigated Drugs:
    • Mannitol
    Finland

  • Study on the Safety and Effects of BMS-986507 with Pembrolizumab and Osimertinib Mesylate in Adults with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • OSIMERTINIB MESYLATE
    • Pembrolizumab
    France Italy The Netherlands Spain

  • Study Comparing Duvelisib with Gemcitabine or Bendamustine for Patients with Relapsed or Resistant T Cell Lymphoma Originating from T Follicular Helper Cells

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • DUVELISIB
    • Bendamustine Hydrochloride
    • Gemcitabine Hydrochloride
    Belgium Czechia Denmark France Germany Italy +3
Previous Page
1 … 231 232 233 234 235 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!